Related Experiment Video
Updated: Sep 27, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
[The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by
Sławomir L Czaban1, Wojciech J Lebkowski, Jacek P Krajewski
1Kliniki Anestezjologii i Intensywnej Terapii, Akademii Medycznej w Białymstoku.
Abstract:
The case of 40 years old man with subarachnoid hemorrhage with intraventricular bleeding and with consecutive cerebro-meningitis is presented. The bacterial pathogen was Enterococcus faecalis sensitive only to glycopeptide antibiotics. The standard therapy with intravenously administered Vancomycin and Teicoplanin was not effective. Because of the worsening of patient's clinical status and clinical symptoms of sepsis the intraventricular Vancomycin (20 mg/day) was introduced. At the second day of the therapy the gradual patient's recovery was observed. The symptoms typical for meningitis diminished as well as cerebro-spinal fluid (CSF) parameters normalized. There was no bacterial growth in the blood serum and in CSF. As we can observe the intraventricular administration of Vancomycin is efficient method of cerebro-meningitis treatment. In our opinion the blood-brain barrier, even pathologically changed by infection, do not allow antibiotics to penetrate CSF, even in the maximal intravenous doses. In the cases of cerebro-meningitis caused by bacteria sensitive only to glycopeptide antibiotics, the intraventricular administration of the drug might be an alternative way of therapy especially when the doses of intravenous antibiotics need to be reduced.
Insights
Intraventricular Vancomycin effectively treated cerebro-meningitis caused by Enterococcus faecalis when intravenous therapy failed. This approach bypasses the blood-brain barrier for direct antibiotic delivery to the cerebrospinal fluid (CSF).
Area of Science:
- Neuroscience
- Infectious Diseases
- Pharmacology
Background:
- Subarachnoid hemorrhage with intraventricular bleeding can lead to cerebro-meningitis.
- Enterococcus faecalis, a pathogen resistant to standard intravenous glycopeptide antibiotics, can cause severe infections.
- The blood-brain barrier often limits antibiotic penetration into the cerebrospinal fluid (CSF).
Observation:
- A 40-year-old male patient presented with subarachnoid hemorrhage, intraventricular bleeding, and cerebro-meningitis due to Enterococcus faecalis.
- Standard intravenous Vancomycin and Teicoplanin were ineffective, and the patient's condition worsened with sepsis.
- Intraventricular Vancomycin (20 mg/day) was administered due to the ineffectiveness of intravenous therapy.
Findings:
- The patient showed gradual recovery within two days of intraventricular Vancomycin administration.
- Meningitis symptoms resolved, and cerebrospinal fluid (CSF) parameters normalized.
- No bacterial growth was detected in blood serum or CSF, indicating successful eradication of Enterococcus faecalis.
Implications:
- Intraventricular Vancomycin is an effective treatment for cerebro-meningitis, particularly when caused by resistant bacteria.
- Direct intraventricular antibiotic administration can overcome blood-brain barrier limitations for treating central nervous system infections.
- This therapeutic strategy offers an alternative for managing cerebro-meningitis when intravenous antibiotic efficacy is compromised or dose reduction is necessary.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Endocarditis III: Medical Management
Cryptococcal Meningitis
